Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between June 4, 2015, and June 10, 2015. The filing documents the closing of Evolent Health, Inc.'s initial public offering (IPO) and the adoption of new corporate governance documents.
Key Financial Metrics and Capital Structure
The filing details the capitalization resulting from the IPO but does not provide operational financial metrics such as revenue, profit, cash flow, or margins.
- Shares Issued: 13,225,000 shares of Class A common stock.
- Underwriters: J.P. Morgan Securities LLC and Goldman, Sachs & Co. (representatives).
- Option Exercise: The underwriters' option to purchase an additional 1,725,000 shares was exercised in full.
- Ownership Concentration: Post-IPO, The Advisory Board Company, UPMC, TPG Growth II BDH, L.P., and TPG Eagle Holdings, L.P. collectively own approximately 67.8% of the voting power.
Material Changes
The primary material change is the transition to a publicly traded company via the IPO closing on June 10, 2015. Additionally, on June 4, 2015, the Company's Amended and Restated Certificate of Incorporation and Amended and Restated By-laws became effective.
Agreements, Risks, and Contingencies
In connection with the IPO, the Company entered into several material definitive agreements:
- Underwriting Agreement: Governs the sale of shares to the public.
- Stockholders Agreement: Defines rights and obligations among major shareholders.
- Registration Rights Agreement: Provides rights for certain shareholders to register their shares for public sale.
- Exchange Agreement: Facilitates the exchange of interests between the Company and certain shareholders.
- Operating Agreement: Third Amended and Restated Operating Agreement of Evolent Health LLC.
- Tax Receivables Agreement: Addresses tax benefits and payments between the Company and certain stockholders.
The filing does not contain specific management commentary on future guidance, risks, or contingencies beyond the standard disclosures referenced in the Registration Statement on Form S-1.
Investor Verification Checklist
- Verify the final IPO price per share and total net proceeds, which are not explicitly stated in this 8-K text.
- Review the Registration Statement on Form S-1 (File No. 333-203852) for detailed descriptions of the Stockholders, Registration Rights, Exchange, and Tax Receivables agreements.
- Confirm the specific terms of the underwriters' option exercise and any lock-up periods associated with the major shareholders holding 67.8% of voting power.
- Examine the Amended and Restated Certificate of Incorporation and By-laws (Exhibits 3.1 and 3.2) for changes to corporate governance and capital structure.